Global Healthcare Biosensors IoT Market: North America will account for higher market share by Region driven by High demand for portable biosensors will lead the demand for healthcare biosensors IoT: Global Market Analysis 2013 – 2017 and Forecast 2018 – 2024

Global Healthcare Biosensors IoT Market: North America will account for higher market share by Region driven by High demand for portable biosensors will lead the demand for healthcare biosensors IoT: Global Market Analysis 2013 – 2017 and Forecast 2018 – 2024

Market Scenario

Global Healthcare Biosensors IoT Market size was valued over USD 17 billion in 2017 and is expected to witness growth of ~8% CAGR from 2018 to 2024. Global Healthcare Biosensors IoT Market is driven by growing awareness regarding diabetes self-management has enabled integration of advanced technology in the glucometers driving the Global Healthcare Biosensors IoT Market growth. For instance, newly developed glucometers have embedded microchips that allows accurate and quick detection of sugar levels at home. Rising preference for such technology variant diabetic biosensors have boosted the industry growth significantly. As per WHO, number of diabetic patients globally in 2016 were around 422 million that have escalated demand for glucose biosensors. Biosensors for measuring blood metabolites such as lactate, glucose, creatinine, and urea, using both optical and electrochemical modes of transduction, are being routinely used and commercially developed in the point of care testing, laboratories, and for self-testing in the case of glucose monitoring. Biosensors have applications in various segments in the healthcare industry. Global Healthcare Biosensors IoT Market Extended use of biosensors in various industries such as medical diagnostics, agricultural and food diagnostic industry has stimulated the demand for biosensors. Wide ranging applications of biosensors in diagnosis of various diseases such as diabetes, cholesterol, haemophilia will impact the industry demand positively. American population suffers from around 7000 rare diseases driving the demand for biosensors. Significant funding is been made in Europe by Max-Planck Institute in collaboration with the Federal Government of Germany and other German states. The European Molecular Biology Laboratory’s European Institute (EMBL-EBI) and BBSRC, with support by the UK Government, made a commitment of approximately USD 93 million for ELIXIR research infrastructure in 2012. In addition, the Chinese Government is also investing heavily on its computing infrastructure majorly via the China Grid initiated by Chinese Academy of Sciences and Ministry of Education and the China National Grid (CNGrid) supported by the Ministry of Science and Technology. Presence of such favourable initiatives is expected to have a positive impact on the biosensors market. Market Segmentation By Product Type • Wearable • Non-wearable By Technology • Electrochemical • Optical • Thermal • Piezoelectric • Others By Application • Blood glucose testing • Cholesterol testing • Blood gas analysis • Pregnancy testing • Drug Discovery • Infectious disease testing • Others By End Use • Point of care testing • Home healthcare diagnostics • Research laboratories • Others The above data will be provided for following regions/countries from 2013-2024 (USD Million) • North America o U.S. o Canada • Europe o Germany o UK o France o Spain o Italy • Asia Pacific o China o India o Japan o Australia • Latin America o Argentina o Brazil o Mexico • Middle East and Africa o South Africa o Saudi Arabia What information is covered in report? • Actual market numbers from 2013-2017, estimates and forecasts from 2018 to 2024 • Detailed market segmentation and market share analysis of each segment • Technology and regulatory landscape and reimbursement scenario • Impact analysis of various drivers and trends • Market segmentation and landscape • Competitive landscape, 2017 Global Compounding Pharmacies Market - Industry Market Analysis and Forecast 2017 – 2024

Table of Contents

Chapter 1 Research Methodology 1.1. Research Methodology 1.2. Market definition 1.3. Assumptions and Acronyms Used 1.4. Data Sources 1.4.1. Secondary 1.4.1.1. Paid 1.4.1.2. Unpaid 1.4.2. Primary Chapter 2 Executive Summary 2.1. Global healthcare biosensors IoT market overview 2.1.1. Product 2.1.2. Application 2.1.3. Therapeutic area Chapter 3 Global Healthcare Biosensors IoT Market, Industry Insights 3.1. Market segmentation and scope of study 3.2. Market Drivers and their impact analysis 3.2.1. Market Drivers 3.2.1.1. Rapid technological changes in U.S 3.2.1.2. Rising prevalence of diabetes globally 3.2.1.3. Extended applications in field of medical in U.S. 3.2.1.4. High demand for portable biosensors in Europe and Asia Pacific 3.2.2. Market restraints 3.2.2.1. Lack of skilled lab technicians and healthcare parishioners in developing economies 3.3. Market share analysis 3.3.1. By type 3.3.2. By technology 3.3.3. By medical application 3.3.4. By end-use 3.4. Reimbursements scenario 3.4.1. U.S. 3.4.2. Europe 3.5. Regulations landscape 3.5.1. U.S. 3.5.2. Europe 3.6. Competitive analysis 3.6.1. Key strategic initiatives 3.6.2. Regional presence 3.6.3. Product overview 3.7. Porter’s analysis 3.8. PESTEL analysis Chapter 4 Global Healthcare Biosensors IoT Market, By Product Type 4.1. Key segment trends 4.2. Wearable Devices 4.2.1. Market size, by region, 2013 - 2024 4.3. Non-wearable Devices 4.3.1. Market size, by region, 2013 - 2024 4.3.2. Key Trends in Global Healthcare Biosensors IoT Market Chapter 5 Global Healthcare Biosensors IoT Market, By Application 5.1. Key segment trends 5.2. Blood glucose testing 5.2.1. Market size, by region, 2013 - 2024 5.3. Cholesterol testing 5.3.1.1. Market size, by region, 2013 - 2024 5.4. Blood gas analysis 5.4.1.1. Market size, by region, 2013 - 2024 5.5. Pregnancy testing 5.5.1.1. Market size, by region, 2013 - 2024 5.6. Drug Discovery 5.6.1.1. Market size, by region, 2013 - 2024 5.7. Infectious disease testing 5.7.1.1. Market size, by region, 2013 - 2024 5.8. Others 5.8.1. Market size, by region, 2013 - 2024 Chapter 6 Global Healthcare Biosensors IoT Market, By Technology 6.1. Key segment trends 6.2. Electrochemical 6.2.1. Market size, by region, 2013 - 2024 6.3. Optical 6.3.1. Market size, by region, 2013 - 2024 6.4. Thermal 6.4.1. Market size, by region, 2013 - 2024 6.5. Piezoelectric 6.5.1. Market size, by region, 2013 - 2024 6.6. Others 6.6.1. Market size, by region, 2013 - 2024 Chapter 7 Global Healthcare Biosensors IoT Market, By End-Use 7.1. Point of care testing 7.1.1. Market size, by region, 2013 - 2024 7.2. Home healthcare diagnostics 7.2.1. Market size, by region, 2013 - 2024 7.3. Research laboratories 7.3.1. Market size, by region, 2013 - 2024 7.4. Others 7.4.1. Market size, by region, 2013 - 2024 Chapter 8 Global Healthcare Biosensors IoT Market, By Region 8.1. Key regional trends 8.2. North America 8.2.1. Market size, by country, 2013 – 2024 8.2.2. Market size, by type, 2013 – 2024 8.2.3. Market size, by application, 2013-2014 8.2.4. Market size, by technology, 2013-2014 8.2.5. Market size, by end users, 2013-2014 8.2.6. U.S. 8.2.6.1. Market size, by type, 2013 – 2024 8.2.6.2. Market size, by application, 2013-2014 8.2.6.3. Market size, by technology, 2013-2014 8.2.6.4. Market size, by end users, 2013-2014 8.2.7. Canada 8.2.7.1. Market size, by type, 2013 – 2024 8.2.7.2. Market size, by application, 2013-2014 8.2.7.3. Market size, by technology, 2013-2014 8.2.7.4. Market size, by end users, 2013-2014 8.3. Europe 8.3.1. Market size, by country, 2013 – 2024 8.3.2. Market size, by type, 2013 – 2024 8.3.3. Market size, by application, 2013-2014 8.3.4. Market size, by technology, 2013-2014 8.3.5. Market size, by end users, 2013-2014 8.3.6. Germany 8.3.6.1. Market size, by type, 2013 – 2024 8.3.6.2. Market size, by application, 2013-2014 8.3.6.3. Market size, by technology, 2013-2014 8.3.6.4. Market size, by end users, 2013-2014 8.3.7. UK 8.3.7.1. Market size, by type, 2013 – 2024 8.3.7.2. Market size, by application, 2013-2014 8.3.7.3. Market size, by technology, 2013-2014 8.3.7.4. Market size, by end users, 2013-2014 8.3.8. France 8.3.8.1. Market size, by type, 2013 – 2024 8.3.8.2. Market size, by application, 2013-2014 8.3.8.3. Market size, by technology, 2013-2014 8.3.8.4. Market size, by end users, 2013-2014 8.3.9. Spain 8.3.9.1. Market size, by type, 2013 – 2024 8.3.9.2. Market size, by application, 2013-2014 8.3.9.3. Market size, by technology, 2013-2014 8.3.9.4. Market size, by end users, 2013-2014 8.3.10. Italy 8.3.10.1. Market size, by type, 2013 – 2024 8.3.10.2. Market size, by application, 2013-2014 8.3.10.3. Market size, by technology, 2013-2014 8.3.10.4. Market size, by end users, 2013-2014 8.3.11. Russia 8.3.11.1. Market size, by type, 2013 – 2024 8.3.11.2. Market size, by application, 2013-2014 8.3.11.3. Market size, by technology, 2013-2014 8.3.11.4. Market size, by end users, 2013-2014 8.4. Asia Pacific 8.4.1. Market size, by country, 2013 – 2024 8.4.2. Market size, by type, 2013 – 2024 8.4.3. Market size, by application, 2013-2014 8.4.4. Market size, by technology, 2013-2014 8.4.5. Market size, by end users, 2013-2014 8.4.6. India 8.4.6.1. Market size, by type, 2013 – 2024 8.4.6.2. Market size, by application, 2013-2014 8.4.6.3. Market size, by technology, 2013-2014 8.4.6.4. Market size, by end users, 2013-2014 8.4.7. China 8.4.7.1. Market size, by type, 2013 – 2024 8.4.7.2. Market size, by application, 2013-2014 8.4.7.3. Market size, by technology, 2013-2014 8.4.7.4. Market size, by end users, 2013-2014 8.4.8. Japan 8.4.8.1. Market size, by type, 2013 – 2024 8.4.8.2. Market size, by application, 2013-2014 8.4.8.3. Market size, by technology, 2013-2014 8.4.8.4. Market size, by end users, 2013-2014 8.4.9. Australia 8.4.9.1. Market size, by type, 2013 – 2024 8.4.9.2. Market size, by application, 2013-2014 8.4.9.3. Market size, by technology, 2013-2014 8.4.9.4. Market size, by end users, 2013-2014 8.5. Latin America 8.5.1. Market size, by country, 2013 – 2024 8.5.2. Market size, by type, 2013 – 2024 8.5.3. Market size, by application, 2013-2014 8.5.4. Market size, by technology, 2013-2014 8.5.5. Market size, by end users, 2013-2014 8.5.6. Argentina 8.5.6.1. Market size, by type, 2013 – 2024 8.5.6.2. Market size, by application, 2013-2014 8.5.6.3. Market size, by technology, 2013-2014 8.5.6.4. Market size, by end users, 2013-2014 8.5.7. Brazil 8.5.7.1. Market size, by type, 2013 – 2024 8.5.7.2. Market size, by application, 2013-2014 8.5.7.3. Market size, by technology, 2013-2014 8.5.7.4. Market size, by end users, 2013-2014 8.5.8. Mexico 8.5.8.1. Market size, by type, 2013 – 2024 8.5.8.2. Market size, by application, 2013-2014 8.5.8.3. Market size, by technology, 2013-2014 8.5.8.4. Market size, by end users, 2013-2014 8.6. Middle East and Africa 8.6.1. Market size, by country, 2013 – 2024 8.6.1.1. Market size, by type, 2013 – 2024 8.6.1.2. Market size, by application, 2013-2014 8.6.1.3. Market size, by technology, 2013-2014 8.6.1.4. Market size, by end users, 2013-2014 8.6.2. South Africa 8.6.2.1. Market size, by type, 2013 – 2024 8.6.2.2. Market size, by application, 2013-2014 8.6.2.3. Market size, by technology, 2013-2014 8.6.2.4. Market size, by end users, 2013-2014 8.6.3. Saudi Arabia 8.6.3.1. Market size, by type, 2013 – 2024 8.6.3.2. Market size, by application, 2013-2014 8.6.3.3. Market size, by technology, 2013-2014 8.6.3.4. Market size, by end users, 2013-2014 Chapter 9 Consolidations 9.1. Mergers and Acquisitions 9.2. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements 9.3. Patent Analysis 9.4. Key players 9.4.1. Abbott Laboratories 9.4.1.1. Company overview 9.4.1.2. Key financials 9.4.1.3. Product landscape 9.4.1.4. Strategic initiatives 9.4.1.5. SWOT analysis 9.4.2. Bio-Rad International 9.4.2.1. Company overview 9.4.2.2. Key financials 9.4.2.3. Product landscape 9.4.2.4. Strategic initiatives 9.4.2.5. SWOT analysis 9.4.3. Biosensors International 9.4.3.1. Company overview 9.4.3.2. Key financials 9.4.3.3. Product landscape 9.4.3.4. Strategic initiatives 9.4.3.5. SWOT analysis 9.4.4. DuPont Biosensors Materials 9.4.4.1. Company overview 9.4.4.2. Key financials 9.4.4.3. Product landscape 9.4.4.4. Strategic initiatives 9.4.4.5. SWOT analysis 9.4.5. Ercon Inc 9.4.5.1. Company overview 9.4.5.2. Key financials 9.4.5.3. Product landscape 9.4.5.4. Strategic initiatives 9.4.5.5. SWOT analysis 9.4.6. Gwent Group 9.4.6.1. Company overview 9.4.6.2. Key financials 9.4.6.3. Product landscape 9.4.6.4. Strategic initiatives 9.4.6.5. SWOT analysis 9.4.7. Innovative Biosensors 9.4.7.1. Company overview 9.4.7.2. Key financials 9.4.7.3. Product landscape 9.4.7.4. Strategic initiatives 9.4.7.5. SWOT analysis 9.4.8. Johnson & Johnson 9.4.8.1. Company overview 9.4.8.2. Key financials 9.4.8.3. Product landscape 9.4.8.4. Strategic initiatives 9.4.8.5. SWOT analysis 9.4.9. Molecular Devices Corp 9.4.9.1. Company overview 9.4.9.2. Key financials 9.4.9.3. Product landscape 9.4.9.4. Strategic initiatives 9.4.9.5. SWOT analysis 9.4.10. Pinnacle Technology 9.4.10.1. Company overview 9.4.10.2. Key financials 9.4.10.3. Product landscape 9.4.10.4. Strategic initiatives 9.4.10.5. SWOT analysis 9.4.11. QTL Biosystems 9.4.11.1. Company overview 9.4.11.2. Key financials 9.4.11.3. Product landscape 9.4.11.4. Strategic initiatives 9.4.11.5. SWOT analysis 9.4.12. Roche Diagnostics 9.4.12.1. Company overview 9.4.12.2. Key financials 9.4.12.3. Product landscape 9.4.12.4. Strategic initiatives 9.4.12.5. SWOT analysis 9.4.13. SDIX, LLC 9.4.13.1. Company overview 9.4.13.2. Key financials 9.4.13.3. Product landscape 9.4.13.4. Strategic initiatives 9.4.13.5. SWOT analysis 9.4.14. Siemens Healthcare, LLC 9.4.14.1. Company overview 9.4.14.2. Key financials 9.4.14.3. Product landscape 9.4.14.4. Strategic initiatives 9.4.14.5. SWOT analysis 9.4.15. TE connectivity Corporation 9.4.15.1. Company overview 9.4.15.2. Key financials 9.4.15.3. Product landscape 9.4.15.4. Strategic initiatives 9.4.15.5. SWOT analysis 9.4.16. Thermo fisher 9.4.16.1. Company overview 9.4.16.2. Key financials 9.4.16.3. Product landscape 9.4.16.4. Strategic initiatives 9.4.16.5. SWOT analysis 9.4.17. Biosensors International 9.4.17.1. Company overview 9.4.17.2. Key financials 9.4.17.3. Product landscape 9.4.17.4. Strategic initiatives 9.4.17.5. SWOT analysis 9.4.18. Axela Biosensors 9.4.18.1. Company overview 9.4.18.2. Key financials 9.4.18.3. Product landscape 9.4.18.4. Strategic initiatives 9.4.18.5. SWOT analysis 9.4.19. Advanced Biosensor 9.4.19.1. Company overview 9.4.19.2. Key financials 9.4.19.3. Product landscape 9.4.19.4. Strategic initiatives 9.4.19.5. SWOT analysis 9.4.20. Atonomics A/S 9.4.20.1. Company overview 9.4.20.2. Key financials 9.4.20.3. Product landscape 9.4.20.4. Strategic initiatives 9.4.20.5. SWOT analysis 9.4.21. Blu-Si 9.4.21.1. Company overview 9.4.21.2. Key financials 9.4.21.3. Product landscape 9.4.21.4. Strategic initiatives 9.4.21.5. SWOT analysis 9.4.22. Piribo 9.4.22.1. Company overview 9.4.22.2. Key financials 9.4.22.3. Product landscape 9.4.22.4. Strategic initiatives 9.4.22.5. SWOT analysis 9.4.23. Biacore 9.4.23.1. Company overview 9.4.23.2. Key financials 9.4.23.3. Product landscape 9.4.23.4. Strategic initiatives 9.4.23.5. SWOT analysis 9.4.24. Sysmex Corporation 9.4.24.1. Company overview 9.4.24.2. Key financials 9.4.24.3. Product landscape 9.4.24.4. Strategic initiatives 9.4.24.5. SWOT analysis 9.4.25. Pharmaco-Kinesis Corporation 9.4.25.1. Company overview 9.4.25.2. Key financials 9.4.25.3. Product landscape 9.4.25.4. Strategic initiatives 9.4.25.5. SWOT analysis

Inquiry Before Buying

Request Sample

About This Report

Report ID10631
Category Healthcare
Publisher Name
No of Pages
Total Views
Published Date
Contact Us
Call Now